EN DE
STOCK COMPARISON

Jeena Sikho Lifecare vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jeena Sikho Lifecare (JSLL) and HCA Healthcare (HCA) compare, as of Aug 18, 2026.

As of Aug 18, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Jeena Sikho Lifecare trades at ₹517 versus a fair value of ₹393 (-24%), while HCA Healthcare trades at $405 versus $548 (+35%).
Jeena Sikho Lifecare
JSLL.NSE · INR · Healthcare
-24%
upside to fair value
overvalued
Price₹517
Fair Value₹393
Quality77/100
HCA Healthcare
HCA · USD · Health Care
+35%
upside to fair value
undervalued
Price$405
Fair Value$548
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Jeena Sikho LifecareHCA Healthcare
Valuation
29.0×P/E (TTM)14.0×
8.91×P/S (TTM)1.06×
15.29×P/B
20.4×EV/EBITDA7.8×
PEG1.18×
0.8%Dividend yield0.8%
₹4.50Dividend per share$2.94
Profitability
28%Net margin9%
29%Operating margin15%
60%Return on equity136%
38%Return on assets12%
Growth
55%Revenue growth (YoY)4%
57.8%Avg. growth/yr (3Y)7.9%
Avg. growth/yr (5Y)8.0%
Balance & size
0.00×Debt / equity
$750MMarket cap$81B
healthyGrowth qualityhealthy

Jeena Sikho Lifecare leads: 6 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jeena Sikho Lifecareof which business quality 77 · market factors 24 HCA Healthcareof which business quality 66 · market factors 38
ProfitabilityMargins and returns on capital today
98
76
Quality GrowthAre margins and returns improving?
63
61
CashflowEarnings quality: real cash, not paper profit
82
62
Fin. StrengthBalance sheet, leverage, solvency risk
82
39
InvestmentDisciplined investing over empire-building
29
75
Low VolatilityCalm price path (market factor)
35
59
MomentumPrice trend over the last 3–12 months (market factor)
21
26
52W MomentumDistance to the 52-week high (market factor)
16
36
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jeena Sikho Lifecare

DCF Models₹613
Earnings-Based₹625
Dividend Discount₹19.36
Multiples₹309
Asset-Based₹25.18
Growth DCF₹460
Economic Profit₹350
Growth Earnings₹829

16 of 26 models see the stock below the current price.

HCA Healthcare

DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506

6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jeena Sikho Lifecare
Bear ₹253Fair Value ₹393Bull ₹900
₹517 = current price (white tick)
HCA Healthcare
Bear $260Fair Value $548Bull $841
$405 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jeena Sikho Lifecare · Healthcare

Quality score77 · Top 25%
Fair value upside-24% · above median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+35% · Top 25%

Bottom line

As of Aug 18, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Jeena Sikho Lifecare trades at ₹517 versus a fair value of ₹393 (-24%), while HCA Healthcare trades at $405 versus $548 (+35%).

Jeena Sikho Lifecare has the higher quality score (77/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.